etoposide has been researched along with Convalescence in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Brustugun, OT; Engleson, J; Fløtten, Ø; Grønberg, BH; Halvorsen, TO; Hornslien, K; Killingberg, KT; Langer, SW; Madebo, T; Nyman, J; Risum, S; Schytte, T; Tsakonas, G | 1 |
1 trial(s) available for etoposide and Convalescence
Article | Year |
---|---|
Patient-reported health-related quality of life from a randomized phase II trial comparing standard-dose with high-dose twice daily thoracic radiotherapy in limited stage small-cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Convalescence; Deglutition Disorders; Dose Fractionation, Radiation; Dyspnea; Etoposide; Humans; Lung Neoplasms; Neoplasm Staging; Patient Reported Outcome Measures; Quality of Life; Radiotherapy; Small Cell Lung Carcinoma | 2022 |